The inhibitors – a challenge for the management of patients with hereditary haemophilia A

Abstract

Introduction. Our research strategy was aimed at evaluating the possible implication of the type of factor VIII product administered as substitution treatment to haemophilia A patients in the occurrence of inhibitors and their consequences on the management.

Keywords

• haemophilia a
• inhibitors
• neutralizing alloantibodies
• plasma-derived factor viii
• recombinant factor viii